NanoSphere Health Sciences’ Brand Evolve Formulas Partners with Former NHL Star Jeff Friesen Cannabis Investing News
Advaxis Announces FDA Lifts Clinical Hold on Phase 1/2 Combination Study of Axalimogene Filolisbac with Durvalumab Biotech Investing
Arcus Biosciences Announces That Taiho Pharmaceutical Has Exercised Its Option to Develop and Commercialize AB928 in Its Territories Biotech Investing
United Greeneries Welcomes Partnership With The British Columbia Liquor Distribution Board Cannabis Investing News
Naturally Splendid Engages Industry Expert in R&D Food Development to Advisory Board Member Cannabis Investing News
CohBar Initiates Clinical Study with First-in-human Dosing of CB4211, a Novel Mitochondria Based Therapeutic for the Treatment of NASH Biotech Investing
